Dual Targeting of DNA Damage Response Proteins Implicated in Cancer Radioresistance

Area of Science:

• Oncology
• Molecular Biology
• Drug Design

Background:

• Ionizing radiation is crucial for cancer treatment but faces challenges from cancer cell radioresistance.
• Cancer cells can develop resistance to radiation therapy by activating DNA damage response and repair mechanisms.
• Platinum-based drugs can enhance tumor radiosensitivity but cause severe adverse effects.

Purpose of the Study:

• To identify novel therapeutic strategies to overcome cancer radioresistance.
• To develop compounds that target key DNA damage repair factors to sensitize cancer cells to radiation.
• To explore computer-aided drug design for generating potential drug candidates.

Main Methods:

• Utilized a computer-aided drug design approach for *ab initio* compound generation.
• Focused on designing compounds with drug-like properties.
• Targeted two proteins implicated in multiple DNA repair pathways.

Main Results:

• Generated a novel chemical compound with potential drug-like properties.
• The compound is designed to target key proteins involved in DNA repair pathways.
• This approach aims to enhance cancer cell vulnerability to irradiation.

Conclusions:

• Targeting DNA damage repair factors can enhance cancer cell killing and reduce side effects.
• The developed compound shows potential for co-administration with radiation therapy.
• Findings may inform clinical decisions for combined treatment strategies.